Jason Lohmueller

6PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMicro-manipulationReaction engineering (excl. nuclear reactions)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 08, 2026
PSCA CAR Vδ1 T cells: a safer off-the-shelf CAR T therapy for pancreatic cancer?

|Jul 25, 2024
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays.

Youngbin Cho, Matthew S Laird, Teddi Bishop

|Oct 04, 2023
Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors.

Michael Kvorjak, Elisa Ruffo, Yaniv Tivon

|May 10, 2023
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting.

Elisa Ruffo, Adam A Butchy, Yaniv Tivon

|Mar 13, 2023
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors.

Konstantinos Lontos, Yiyang Wang, Supriya K Joshi

|Jun 16, 2021
The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse.

Shunsuke Kataoka, Priyanka Manandhar, Judong Lee

Pageof 1

Frequent Collaborators

2 joint publications

Michael Kvorjak

2 joint publications

Alexander Deiters

2 joint publications

Elisa Ruffo

2 joint publications

Avani Parikh